Director/PDMR Shareholding

RNS Number : 2865F

GlaxoSmithKline PLC

18 February 2015

 

Notification of Transactions of

Directors and Persons Discharging Managerial Responsibility

Vesting of conditional share awards made under

the GlaxoSmithKline Share Value Plan

This notification sets out the vesting of awards over Ordinary Shares made in 2012 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group.

The restricted period for the 2012 SVP awards, which commenced on 22 August 2012, has now ended and the awards made have vested. The vesting of the SVP awards on 17 February 2015 made to individuals who have subsequently been appointed Persons Discharging Managerial Responsibility (PDMR), are given in the table below.

Name of PDMR	Number of Ordinary Shares vested	Number of ADS  vested
Mr R Connor	17,920
Mr N Hirons		5,740
Mrs V Whyte	13,070

The Company and PDMRs were advised of these transactions on 18 February 2015.

The fair market values of an Ordinary Share and of an ADS of GlaxoSmithKline plc at the point of vesting on 17 February 2015 were £15.475 and US$47.71 respectively.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

18 February 2015

 

END

 

 

RDSQVLFFELFEBBK